Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 May;33(5):501–511. doi: 10.1038/bjc.1976.81

Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

G M Taylor, C B Freeman, R Harris
PMCID: PMC2024968  PMID: 1064430

Abstract

Thymidine incorporation in vitro by remission lymphocytes from a total of 6 patients with acute myeloid leukaemia (AML) was measured following stimulation by autochthonous and allogeneic AML blasts and cell lines. The early peak response to autochthonous blasts in 2 of these patients (48-72 h) is consistent with the concept of a population of lymphocytes pre-immunized to antigens carried by the blasts. Although stimulation in one patient was increased in the presence of more stimulating (S) blasts than responding (R) lymphocytes, positive responses in other tests were obtained at an S : R ratio of 1 : 1-5. When different methods of treatment of the stimulating autochthonous blasts were compared with untreated cells, mitomycin C gave the highest stimulation indices 2 out of 3 tests. Tissue culture medium in which autochthonous blasts had been incubated for 3-5 days failed to stimulate either remission lymphocytes alone, or combined cultures of lymphocytes with autochthonous or allogeneic blasts, suggesting that mitogenic factors released from autochthonous blasts are not responsible for lymphocyte stimulation. Treatment of autochthonous or allogeneic AML blasts with glycine-HC1(pH 3-0) to remove putative "blocking" factors failed to increase the stimulatory capacity of the leukaemic blasts.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambus U., Mavlight G. M., Gutterman J. U., McBride C. M., Hersh E. M. Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy. Int J Cancer. 1974 Sep 15;14(3):291–300. doi: 10.1002/ijc.2910140302. [DOI] [PubMed] [Google Scholar]
  2. Bausher J. C., Smith R. T. Studies of the Epstein-Barr virus-host relationship: autochthonous and allogeneic lymphocyte stimulation by lymphoblast cell lines in mixed cell culture. Clin Immunol Immunopathol. 1973 Jan;1(2):270–281. doi: 10.1016/0090-1229(73)90027-5. [DOI] [PubMed] [Google Scholar]
  3. Birnbaum G., Siskind G. W., Weksler M. E. Autologous and allogeneic stimulation of peripheral human leukocytes. Cell Immunol. 1972 Jan;3(1):44–52. doi: 10.1016/0008-8749(72)90224-9. [DOI] [PubMed] [Google Scholar]
  4. Bondevik H., Thorsby E. The human mixed lymphocyte culture (MLC) interaction after in vivo alloimmunization. I. Kinetics. Cell Immunol. 1974 Mar 30;11(1-3):409–418. doi: 10.1016/0008-8749(74)90039-2. [DOI] [PubMed] [Google Scholar]
  5. Bondevik H., Thorsby E. The human mixed-lymphocyte culture (MLC) interaction after in vivo allo-immunization. II. HL-A specificity of early proliferative response. Cell Immunol. 1974 Sep;13(3):385–396. doi: 10.1016/0008-8749(74)90258-5. [DOI] [PubMed] [Google Scholar]
  6. Char D. H., Lepourhiet B. G., Herberman R. B. Cutaneous delayed hypersensitivity responses to tumor-associated and other antigens in acute leukemia. Int J Cancer. 1973 Sep 15;12(2):409–419. doi: 10.1002/ijc.2910120212. [DOI] [PubMed] [Google Scholar]
  7. Freeman C. B., Harris R., Geary C. G., Leyland M. J., MaCiver J. E., Delamore I. W. Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia. Br Med J. 1973 Dec 8;4(5892):571–573. doi: 10.1136/bmj.4.5892.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fridman W. H., Kourilsky F. M. Stimulation of lymphocytes by autologous leukaemic cells in acute leukaemia. Nature. 1969 Oct 18;224(5216):277–279. doi: 10.1038/224277a0. [DOI] [PubMed] [Google Scholar]
  9. Gutterman J. U., Mavligit G. M., Reed R. C., Hersh E. M. Immunochemotherapy of human cancer. Semin Oncol. 1974 Dec;1(4):409–423. [PubMed] [Google Scholar]
  10. Gutterman J. U., Mavligit G., McCredie K. B., Bodey G. P., Sr, Freireich E. J., Hersh E. M. Antigen solubilized from human leukemia: lymphocyte stimulation. Science. 1972 Sep 22;177(4054):1114–1115. doi: 10.1126/science.177.4054.1114. [DOI] [PubMed] [Google Scholar]
  11. Gutterman J. U., Mavligit G., McCredie K. B., Freireich E. J., Hersh E. M. Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsiveness. Int J Cancer. 1973 May;11(3):521–526. doi: 10.1002/ijc.2910110303. [DOI] [PubMed] [Google Scholar]
  12. Gutterman J. U., Rossen R. D., Butler W. T., McCredie K. B., Bodey G. P., Sr, Freireich E. J., Hersh E. M. Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia. N Engl J Med. 1973 Jan 25;288(4):169–175. doi: 10.1056/NEJM197301252880401. [DOI] [PubMed] [Google Scholar]
  13. Han T., Minowada J. A unique 'leukaemic' T lymphoid cell line: absence of stimulating effect in mixed lymphocyte reaction. Lack of MLR-S in leukaemic T lymphoid cells. Clin Exp Immunol. 1973 Dec;15(4):535–541. [PMC free article] [PubMed] [Google Scholar]
  14. Han T., Moore G. E., Sokal J. E. In vitro lymphocyte response to autologous cultured lymphoid cells. Proc Soc Exp Biol Med. 1971 Mar;136(3):976–979. doi: 10.3181/00379727-136-35409. [DOI] [PubMed] [Google Scholar]
  15. Junge U., Hoekstra J., Deinhardt F. Stimulation of peripheral lymphocytes by allogeneic and autochthonous mononucleosis lymphocyte cell lines. J Immunol. 1971 May;106(5):1306–1315. [PubMed] [Google Scholar]
  16. Klein G., Steiner M., Wiener F., Klein E. Human leukemia-associated anti-nuclear reactivity. Proc Natl Acad Sci U S A. 1974 Mar;71(3):685–689. doi: 10.1073/pnas.71.3.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Powles R. L., Balchin L. A., Fairley G. H., Alexander P. Recognition of leukaemia cells as foreign before and after autoimmunization. Br Med J. 1971 Feb 27;1(5747):486–489. doi: 10.1136/bmj.1.5747.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reedman B. M., Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer. 1973 May;11(3):499–520. doi: 10.1002/ijc.2910110302. [DOI] [PubMed] [Google Scholar]
  19. Schweitzer M., Melief C. J., Eijsvoogel V. P. Failure to demonstrate immunity to leukemia associated antigens by lymphocyte transformation in vitro. Int J Cancer. 1973 Jan 15;11(1):11–18. doi: 10.1002/ijc.2910110103. [DOI] [PubMed] [Google Scholar]
  20. Steel C. M., Hardy D. A., Ling N. R., Dick H. M., Mackintosh P., Crichton W. B. The interaction of normal lymphocytes nd cells from lymphoid cell lines. 3. Studies on activation in an autochthonous system. Immunology. 1973 Jan;24(1):177–189. [PMC free article] [PubMed] [Google Scholar]
  21. Svedmyr E. A., Deinhardt F., Klein G. Sensitivity of different target cells to the killing action of peripheral lymphocytes stimulated by autologous lymphoblastoid cell lines. Int J Cancer. 1974 Jun 15;13(6):891–903. doi: 10.1002/ijc.2910130617. [DOI] [PubMed] [Google Scholar]
  22. Taylor G. M., Harris R., Freeman C. B. Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia. Br J Cancer. 1976 Feb;33(2):137–143. doi: 10.1038/bjc.1976.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Thorsby E. The human major histocompatibility system. Transplant Rev. 1974;18:51–129. [PubMed] [Google Scholar]
  24. Vánky F., Stjernswärd J., Klein G., Steiner L., Lindberg L. Tumor-associated specificity of serum-mediated inhibition of lymphocyte stimulation by autochthonous human tumors. J Natl Cancer Inst. 1973 Jul;51(1):25–32. doi: 10.1093/jnci/51.1.25. [DOI] [PubMed] [Google Scholar]
  25. Walker J. S., Davis D., Davies P., Freeman C. B., Harris R. Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors. Br J Cancer. 1973 Mar;27(3):203–211. doi: 10.1038/bjc.1973.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Weksler M. E. Lymphocyte transformation induced by autologous cells. II. Stimulation by mitogen-induced lymphoblasts. J Exp Med. 1973 Mar 1;137(3):799–806. doi: 10.1084/jem.137.3.799. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES